Clinical Trial Update: A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple oral doses of SKL15508 in adults with stable …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SKL15508

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED